Table 2 Relationships between the expression of YWHAE and clinicopathological parameters
Groups | Cases | Low | High | Positive rate (%) | P-value | High expression rate (%) | P-value | ||
|---|---|---|---|---|---|---|---|---|---|
(−) | (+) | (++) | (+++) | ||||||
Age at diagnosis | |||||||||
 < 55 | 54 | 4 | 13 | 18 | 19 | 92.59 | P = 0.066 | 68.52 | P = 0.651 |
 ≥ 55 | 51 | 0 | 14 | 18 | 19 | 100.00 | 72.55 | ||
Pathological type | |||||||||
 Serous | 71 | 2 | 14 | 28 | 27 | 97.18 | P = 0.222 | 77.46 | P = 0.073 |
 Mucinous | 7 | 1 | 3 | 2 | 1 | 85.71 | 42.86 | ||
 Endometrioid | 19 | 1 | 6 | 4 | 8 | 94.73 | 63.16 | ||
 Clear cell carcinoma | 8 | 0 | 4 | 2 | 2 | 100.00 | 50.00 | ||
FIGO stage | |||||||||
 I–II | 44 | 3 | 16 | 12 | 13 | 93.18 | P = 0.307 | 56.82 | P = 0.009 |
 III–IV | 61 | 1 | 11 | 24 | 25 | 98.36 | 80.33 | ||
Differentiation | |||||||||
 Well and moderate | 51 | 3 | 13 | 12 | 23 | 94.12 | P = 0.354 | 68.63 | P = 0.687 |
 Poor | 54 | 1 | 14 | 24 | 15 | 98.15 | 72.22 | ||
Lymphatic metastasis | |||||||||
 No | 64 | 4 | 18 | 22 | 20 | 93.75 | P = 0.310 | 65.63 | P = 0.214 |
 Yes | 28 | 0 | 6 | 10 | 12 | 100.00 | 78.57 | ||
 Unknowna | 13 | 0 | 3 | 4 | 6 | 100.00 | 76.92 | ||